Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Do black men need separate prostate cancer screening guidelines?

Erin Marcus, MD
Conditions
November 5, 2012
111 Shares
Share
Tweet
Share

Marc Henderson, a 63-year-old African-American airport executive, isn’t afraid to ask his physician to do a blood test for prostate-specific antigen (PSA), a screening test for prostate cancer. “I’d rather know early on so that it can be treated, rather than sit around in denial until it’s too late,” he said. “If it’s going to help catch something, I have no problems with it.”

Henderson’s views aren’t unusual. For years, doctors have routinely ordered the PSA on men older than 50, along with tests for cholesterol and blood sugar. Just as the goal of screening mammograms is to prevent deaths from breast cancer, the goal of routine PSA testing is to catch prostate cancer early, when it’s easier to treat and more likely to be cured. Prostate cancer is the second leading cause of cancer death among men in the United States, and routine PSA tests have led to the diagnosis of early prostate cancer in millions of men with no symptoms of the disease. Overall, 16 out of 100 men will be diagnosed with prostate cancer during their lifetime, and 3 out of 100 will die of the disease.

Prostate cancer hits black men especially hard. One out of every 5 black men will be diagnosed with prostate cancer during his lifetime, and 5 out of 100 will die of the disease. Black men are more likely to be diagnosed with prostate cancer that is more aggressive and more advanced than are men of other ethnicities. They are also more likely to develop the disease at a younger age than other men.

Unfortunately, the PSA isn’t a great test. It’s often abnormal in men who don’t have cancer (and sometimes, it’s normal in men who do have cancer). Widespread testing has led to millions of men without prostate cancer undergoing biopsies, in which a needle is used to take a small piece of the prostate to examine under the microscope. Also, prostate cancer is extremely common, and most early cases don’t spread to other organs. Those that do spread often take many years to progress to the point where they are fatal. Most men with prostate cancer die of other diseases. Because of early detection, many men undergo aggressive treatment for a cancer that, left alone, would not kill them.

Because of these drawbacks, the United States Preventive Services Task Force (USPSTF), a prominent panel of doctors and health experts, recommended earlier this year that men not undergo routine screening. After reviewing several large studies of PSA testing, the panel concluded that the risks of testing — specifically, complications of biopsies and of treatment, such as infections, bleeding, urinary and sexual problems — outweigh the benefit of lives saved as a result of the test.

The USPSTF reported that routine PSA testing saves one man out of 1,000 — at most — from dying of prostate cancer. Meanwhile, out of 1,000 men who are screened, 30 to 40 will develop erectile dysfunction or problems controlling their urination, two will have a heart attack or stroke, and one will develop a potentially life-threatening blood clot as a result of treatment for prostate cancer. In all, the USPSTF reported, 1 out of 3,000 men screened for prostate cancer will die due to complications from surgical treatment.

The studies the USPSTF reviewed didn’t include many black men, and most were done in Europe. Nonetheless, the panel didn’t make a separate recommendation for blacks. Instead, it stated that because so few black men were in the studies, “no firm conclusions can be made about the balance of benefits and harms of PSA-based screening in this population” and described PSA screening based on race as “problematic … in the absence of data.” The panel’s report also cited a recent large U.S. study that did include a large number of black men with early prostate cancer and found no difference in survival at 12 years between those who underwent aggressive prostate surgery, versus those who were closely monitored but didn’t receive prostate cancer treatment.

The leading black physicians’ organization, the National Medical Association (NMA), vehemently disagreed with the USPSTF’s recommendation.

“It just doesn’t make sense,” said Dr. Cedric Bright, a general internist who is an associate professor of medicine at the University of North Carolina at Chapel Hill and a former NMA president. “I’ve seen enough prostate cancer that started early and was more aggressive.” He added that the panel’s conclusions “may be more generalizable to those who are of European background. There are very few African-Americans in the studies.”

In a statement issued in response to the USPSTF recommendation, the NMA describes PSA screening as “the best method to detect early stage, curable prostate cancers.” The NMA supports the American Urologic Association’s screening guidelines, which include beginning PSA screening at age 40, including a doctor’s office rectal exam as part of the screening, assessing a man’s risk based on his age, ethnicity, family history, and aspects of his PSA result, such as how much it has increased over the past year and whether it is high compared to the size of his prostate. It also encourages men to engage in a discussion of risks and benefits with their physicians, and advocates educating people in the community about prostate cancer and making health care easier to obtain.

The NMA statement cites a 2010 autopsy study of more than 1,000 black and white men in Detroit suggesting that prostate cancer grows more rapidly in black men and/or changes from an indolent to an aggressive form sooner in blacks.

Bright believes there’s a need for more research to study PSA screening’s effectiveness among black men. In the meantime, however, he is worried that insurance companies will respond to the USPSTF’s recommendations by deciding not to cover PSA screening. He says he has already begun to see a “backlash” of men deciding not to be screened.

And while Marc Henderson is aware of the USPSTF’s recommendation, he says it doesn’t affect his decision to get the PSA. “Yes, statistics may be good for the population, but everything in life is individual,” he said. “African-American males need to be cognizant of their health.”

Erin Marcus is an internal medicine physician and writes at New America Media.  This article originally appeared in The Huffington Post and New America Media.

Prev

Waste in medicine is disrespectful to both patients and doctors

November 5, 2012 Kevin 0
…
Next

Stockholm syndrome and Epic's takeover of medical records

November 5, 2012 Kevin 14
…

Tagged as: Oncology/Hematology, Primary Care

Post navigation

< Previous Post
Waste in medicine is disrespectful to both patients and doctors
Next Post >
Stockholm syndrome and Epic's takeover of medical records

More by Erin Marcus, MD

  • Anal health should become a routine conversation topic between doctors and patients

    Erin Marcus, MD
  • a desk with keyboard and ipad with the kevinmd logo

    How to create clear patient education materials

    Erin Marcus, MD
  • a desk with keyboard and ipad with the kevinmd logo

    What happens if Medicaid expansion is undermined

    Erin Marcus, MD

More in Conditions

  • Overcoming Parkinson’s: a journey of laughter and resilience

    Cynthia Poire Mathews, FNP
  • The untold struggles patients face with resident doctors

    Denise Reich
  • Maximize sleep efficiency with stimulus control

    Pedram Navab, DO
  • The endless waves of chronic illness

    Michele Luckenbaugh
  • Surviving and thriving after life’s most difficult moments

    Rebecca Fogg, MBA
  • The surprising power of Play-Doh in pediatric care: How it’s bringing families together

    Alexander Rakowsky, MD
  • Most Popular

  • Past Week

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
    • Safe sex for seniors: Dispelling myths and embracing safe practices [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • Safe sex for seniors: Dispelling myths and embracing safe practices [PODCAST]

      The Podcast by KevinMD | Podcast
    • Overcoming Parkinson’s: a journey of laughter and resilience

      Cynthia Poire Mathews, FNP | Conditions
    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
    • Maximize sleep efficiency with stimulus control

      Pedram Navab, DO | Conditions
    • The Iranian diaspora’s fight for liberty: Overcoming challenges in the largest women’s rights movement of our century

      Montreh Tavakkoli, MD | Physician
    • Surviving clinical rounds: tips and tales from a pediatric hematologist-oncologist [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • How This Doctor Found Purpose After a Devastating Injury
  • House Lawmakers Squabble Over HHS Budget
  • Infant Formula Crisis Exposed FDA and Industry Failings, Lawmakers Say
  • Building Vaccine Trust Among the General Public
  • Is It Business as Usual for the Drug Industry?

Meeting Coverage

  • Phase III Trials 'Hit a Home Run' in Advanced Endometrial Cancer
  • Cannabis Use Common in Post-Surgery Patients on Opioid Tapering
  • Less Abuse With Extended-Release Oxycodone, Poison Center Data Suggest
  • Novel Strategies Show Winning Potential in Ovarian Cancer
  • Children Do Well With Fewer Opiates After Surgery
  • Most Popular

  • Past Week

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
    • Safe sex for seniors: Dispelling myths and embracing safe practices [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • Safe sex for seniors: Dispelling myths and embracing safe practices [PODCAST]

      The Podcast by KevinMD | Podcast
    • Overcoming Parkinson’s: a journey of laughter and resilience

      Cynthia Poire Mathews, FNP | Conditions
    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
    • Maximize sleep efficiency with stimulus control

      Pedram Navab, DO | Conditions
    • The Iranian diaspora’s fight for liberty: Overcoming challenges in the largest women’s rights movement of our century

      Montreh Tavakkoli, MD | Physician
    • Surviving clinical rounds: tips and tales from a pediatric hematologist-oncologist [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...